On March 6^th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Chemistry (Approval Notice).

General Field: Chemistry

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

State of Residence at the Time of Filing: Maryland

Approval Notice Date: March 6^th, 2021

Processing Time: 6 months, 8 days

Case Summary:

A postdoctoral fellow based in Maryland retained the expert services of our law firm to help her in filing an EB-1A (Alien of Extraordinary Ability) petition. With our exceptional experience in leading employment-based immigration petitions, we signed to take her case and assessed her academic accolades. We intended to establish that she was an individual possessing extraordinary ability to receive the petition approval. We ensured that she held a Ph.D. in chemistry and several years of striking merits in the field, and undoubtedly, our client has the necessary knowledge and experience to proceed in her proposed research in the United States.

We listed the 15 peer-reviewed scientific journal articles and conference papers she published, which altogether garnered 301 citations. Her publications have been cited by researchers in at least 33 countries, thereby demonstrating that these publications are terrestrially acknowledged in the field of chemistry. Furthermore, we detailed that she had already conducted 160 reviews for highly acclaimed journals. This proves that she is an active member of the scientific community as well in her area.

To support her petition further, we described our client’s research in her petition packet which focused on the development of biocompatible compact coatings for nanoparticles, including quantum dots and gold nanoparticles, the development of nanoparticle-based biological sensors, and the development of a technique for effectively delivering nanoparticles to cancer cells via anticancer peptides. Her quantum dot and therapeutic nanoparticle research address some of our world’s most pressing issues, including anticancer therapy, drug delivery, and the widespread applications of nanoparticles in biomedical contexts.

Moreover, we incorporated five letters of recommendation received from her fellow well-recognized experts in the field, indicating the superior quality of her research.
One of her recommenders stated:

“In addition to its economic importance, [client’s] platform has offered an important new tool for the development of superior drug delivery mechanisms in the treatment of cancer and other diseases. Her work is, therefore, of major benefit to both the economy and public health.”

Successfully, our client was permitted EB1A approval by the USCIS within 6 months with the help of our constant team coordination with her. We thank her for trusting us throughout the process and congratulate her for achieving this great quantum leap.